Interaction of gadolinium-based MR contrast agents with choline: Implications for MR spectroscopy (MRS) of the breast

Robert E. Lenkinski, Xiaoen Wang, Mostafa Elian, S. Nahum Goldberg

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

It has been shown that magnetic resonance spectroscopy (MRS) can improve the specificity of the MR examination by the spectroscopic detection of choline (Cho). Commonly, the lesion is first visualized on postcontrast studies, and the MRS voxel is prescribed accordingly. The implicit assumption made in this approach is that the presence of gadolinium-based contrast agents will have a negligible effect on the MR spectra obtained from the lesion. In this work, we examined this assumption by determining the effects of six gadolinium-based contrast agents: Magnevist, Multihance, Omniscan, Optimark, ProHance, and Dotarem, on the Cho peak in phantoms and in a rat model for breast cancer. We found that only the three negatively-charged chelates: Magnevist, MultiHance, and Dotarem, broadened the Cho peak in phantoms and reduced the area of the Cho peak in vivo by an average of about 40%. The use of negatively-charged chelates may lead to an underestimation of the levels of Cho present in human breast cancers, since most studies use MRS postcontrast administration. Therefore, we recommend the use of the neutral chelates in MRI/MRS studies of the breast.

Original languageEnglish (US)
Pages (from-to)1286-1292
Number of pages7
JournalMagnetic Resonance in Medicine
Volume61
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Gadolinium
Choline
Contrast Media
Breast
Magnetic Resonance Spectroscopy
Gadolinium DTPA
gadodiamide
Breast Neoplasms
gadobenic acid
gadoterate meglumine

Keywords

  • Breast MRS
  • Choline
  • Contrast agents
  • In vivo
  • Interactions

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Interaction of gadolinium-based MR contrast agents with choline : Implications for MR spectroscopy (MRS) of the breast. / Lenkinski, Robert E.; Wang, Xiaoen; Elian, Mostafa; Goldberg, S. Nahum.

In: Magnetic Resonance in Medicine, Vol. 61, No. 6, 06.2009, p. 1286-1292.

Research output: Contribution to journalArticle

Lenkinski, Robert E. ; Wang, Xiaoen ; Elian, Mostafa ; Goldberg, S. Nahum. / Interaction of gadolinium-based MR contrast agents with choline : Implications for MR spectroscopy (MRS) of the breast. In: Magnetic Resonance in Medicine. 2009 ; Vol. 61, No. 6. pp. 1286-1292.
@article{095b45ca21a1487eb3c12c6622ee8336,
title = "Interaction of gadolinium-based MR contrast agents with choline: Implications for MR spectroscopy (MRS) of the breast",
abstract = "It has been shown that magnetic resonance spectroscopy (MRS) can improve the specificity of the MR examination by the spectroscopic detection of choline (Cho). Commonly, the lesion is first visualized on postcontrast studies, and the MRS voxel is prescribed accordingly. The implicit assumption made in this approach is that the presence of gadolinium-based contrast agents will have a negligible effect on the MR spectra obtained from the lesion. In this work, we examined this assumption by determining the effects of six gadolinium-based contrast agents: Magnevist, Multihance, Omniscan, Optimark, ProHance, and Dotarem, on the Cho peak in phantoms and in a rat model for breast cancer. We found that only the three negatively-charged chelates: Magnevist, MultiHance, and Dotarem, broadened the Cho peak in phantoms and reduced the area of the Cho peak in vivo by an average of about 40{\%}. The use of negatively-charged chelates may lead to an underestimation of the levels of Cho present in human breast cancers, since most studies use MRS postcontrast administration. Therefore, we recommend the use of the neutral chelates in MRI/MRS studies of the breast.",
keywords = "Breast MRS, Choline, Contrast agents, In vivo, Interactions",
author = "Lenkinski, {Robert E.} and Xiaoen Wang and Mostafa Elian and Goldberg, {S. Nahum}",
year = "2009",
month = "6",
doi = "10.1002/mrm.21937",
language = "English (US)",
volume = "61",
pages = "1286--1292",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Interaction of gadolinium-based MR contrast agents with choline

T2 - Implications for MR spectroscopy (MRS) of the breast

AU - Lenkinski, Robert E.

AU - Wang, Xiaoen

AU - Elian, Mostafa

AU - Goldberg, S. Nahum

PY - 2009/6

Y1 - 2009/6

N2 - It has been shown that magnetic resonance spectroscopy (MRS) can improve the specificity of the MR examination by the spectroscopic detection of choline (Cho). Commonly, the lesion is first visualized on postcontrast studies, and the MRS voxel is prescribed accordingly. The implicit assumption made in this approach is that the presence of gadolinium-based contrast agents will have a negligible effect on the MR spectra obtained from the lesion. In this work, we examined this assumption by determining the effects of six gadolinium-based contrast agents: Magnevist, Multihance, Omniscan, Optimark, ProHance, and Dotarem, on the Cho peak in phantoms and in a rat model for breast cancer. We found that only the three negatively-charged chelates: Magnevist, MultiHance, and Dotarem, broadened the Cho peak in phantoms and reduced the area of the Cho peak in vivo by an average of about 40%. The use of negatively-charged chelates may lead to an underestimation of the levels of Cho present in human breast cancers, since most studies use MRS postcontrast administration. Therefore, we recommend the use of the neutral chelates in MRI/MRS studies of the breast.

AB - It has been shown that magnetic resonance spectroscopy (MRS) can improve the specificity of the MR examination by the spectroscopic detection of choline (Cho). Commonly, the lesion is first visualized on postcontrast studies, and the MRS voxel is prescribed accordingly. The implicit assumption made in this approach is that the presence of gadolinium-based contrast agents will have a negligible effect on the MR spectra obtained from the lesion. In this work, we examined this assumption by determining the effects of six gadolinium-based contrast agents: Magnevist, Multihance, Omniscan, Optimark, ProHance, and Dotarem, on the Cho peak in phantoms and in a rat model for breast cancer. We found that only the three negatively-charged chelates: Magnevist, MultiHance, and Dotarem, broadened the Cho peak in phantoms and reduced the area of the Cho peak in vivo by an average of about 40%. The use of negatively-charged chelates may lead to an underestimation of the levels of Cho present in human breast cancers, since most studies use MRS postcontrast administration. Therefore, we recommend the use of the neutral chelates in MRI/MRS studies of the breast.

KW - Breast MRS

KW - Choline

KW - Contrast agents

KW - In vivo

KW - Interactions

UR - http://www.scopus.com/inward/record.url?scp=67049109436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049109436&partnerID=8YFLogxK

U2 - 10.1002/mrm.21937

DO - 10.1002/mrm.21937

M3 - Article

C2 - 19365855

AN - SCOPUS:67049109436

VL - 61

SP - 1286

EP - 1292

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 6

ER -